Research

Andra Stevenson, Ph.D.’01, Returns to UVM to Share Insights on Mentorship and Career Journey

Research by Yvonne Janssen-Heininger, Ph.D., and Reem Aboushousha, Ph.D, uncovered a novel facet of glutaredoxin, a prominent player in humans’ antioxidant defense system . The findings bear substantial implications in the field of cancer biology.

Each summer, many rising second-year medical students engage in clinical, basic science or health policy-related research projects under the guidance of expert faculty. The students choose their topics based on personal passions and immerse themselves in projects tackling medical puzzles and unmet health needs. Engaging in research can be among the most valuable experiences during a medical education.

The University of Vermont and UVM Larner College of Medicine are delighted to announce the upcoming "Dean's Celebration of Excellence in Research," a weeklong celebration dedicated to showcasing the exceptional research endeavors of faculty, research fellows, and graduate students. Held September 18 to 22, 2023, this year’s series promises to be an extraordinary platform for academic discovery and collaboration.

The Larner College of Medicine at the University of Vermont is pleased to announce that their Translational Global Infectious Disease Research Center (TGIR), Center of Biomedical Research Excellence (COBRE) has received Phase II funding from the National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH).

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics, received a substantial R35 MIRA grant from NIGMS for his study “Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age.” This five-year project—the department’s first NIH grant—addresses intraoperative hypotension in neonates, infants, and older adults under anesthesia.

In 2021, University of Vermont neuroscientists received a $5.5 million National Institute of Health (NIH) grant to support the Phase II segment of the HEALthy Brain and Child Development (HBCD) Study. The HBCD Study, the largest long-term study of early brain and child development in the United States, aims to comprehensively collect data on brain development from birth through early childhood, shedding light on the factors that shape a young person's life trajectory.

Larner Researcher’s Collaborative Efforts Propel RSV Vaccine Development and Offer Hope for Infant Health.

Today, in the era of AI, medical digital twins hold great promise for helping diagnose and treat the population in the future. UVM Professor Gary An, M.D., a surgeon and computational biology and mathematical modeling expert, has been working on developing and researching computational models for such diseases as sepsis and COVID-19 for over 20 years. His recent research has centered on developing digital twins of the human immune system.

Thanks to positive results from a new clinical trial in which the UVM Cancer Center and Chris Holmes, M.D., Ph.D., professor of medicine, played a role, the five to 25 percent of cancer patients who develop venous thrombosis will no longer need to inject themselves with a blood thinner.